Insight Molecular Diagnostics Inc (IMDX) Implied Volatility Current

Tracking IMDX implied volatility helps you identify when options premiums on Insight Molecular Diagnostics Inc are historically cheap or expensive, and where the best trades are hiding. Insight Molecular Diagnostics Inc implied volatility reflects the market's expectation of future price movement: when IMDX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Insight Molecular Diagnostics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IMDX, tracking metrics like IMDX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IMDX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system.

OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IMDX implied volatility sits today versus where it has been. Our scanner ranks Insight Molecular Diagnostics Inc implied volatility against its historical range, surfaces extremes in IMDX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Insight Molecular Diagnostics Inc IV is rich or cheap — measure it, then act on it.